Board Meeting30 Oct 2026, 03:06 pm
Sudarshan Pharma to Raise ₹72 Cr via Warrants to Promoters
AI Summary
Sudarshan Pharma Industries Ltd announced that its Board of Directors has approved a proposal to raise funds by issuing and allotting up to 72,00,00,000 (Seventy-Two Crores) Warrants convertible into Equity Shares to promoters Mr. Hemal Mehta and Mr. Sachin Mehta. The allotment will be on a preferential basis at a price determined as per SEBI ICDR Regulations. This move is subject to regulatory and statutory approvals, as well as shareholder approval at an upcoming Extraordinary General Meeting (EGM). The Board meeting was held on October 29, 2026.
Key Highlights
- Board approved raising ₹72 Cr via convertible warrants.
- Warrants to be issued to promoters Mr. Hemal Mehta and Mr. Sachin Mehta.
- Fundraising subject to regulatory and shareholder approvals.
- Shareholder approval to be sought via EGM.
Price Impact
More from SUDARSHAN